COX-2-Selective Inhibitors to Treat Asprin-Insensitive Thromboxane Biosynthesis: A Randomised Cross-Over Trial

  • Eikelboom, John (Chief Investigator)
  • Norman, Paul (Chief Investigator)
  • Hankey, Graeme (Chief Investigator)
  • Staton, J. (Chief Investigator)

    Project Details

    StatusFinished
    Effective start/end date1/01/04 → 31/12/05

    Funding

    • National Heart Foundation of Australia